Hyperfine concludes Contrast PMR study enrolment for Swoop MRI system

Hyperfine has completed patient enrolment in its multi-centre Contrast PMR study examining the use of contrast agents with the company’s portable Swoop MRI system. Hyperfine plans to use the data to support its first expanded indication submission for the Swoop system since FDA clearance. The study focuses on Swoop’s ability to visualise lesions linked to blood-brain barrier disruption using gadolinium-based contrast. Credit: mi_viri / Shutterstock.com. Hyperfine has completed patient enrolment in its multi-centre Contrast PMR study examining the use of contrast agents with the company’s portable Swoop MRI system. The prospective study will investigate whether contrast-enhanced, ultra-low-field magnetic resonance imaging…

Source: Medical Device Network